View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Schreiner MediPharm
26 February 2015

Schreiner MediPharm to Introduce New Label and Cap Combination Anti-Counterfeiting Solution at INTERPHEX NYC 2015

Schreiner MediPharm will introduce a new label and cap combination anti-counterfeiting solution to the US market at INTERPHEX NYC 2015 from April 21-23 at the Jacob K Javits Center.

The company will be at booth #1053.

Flexi-Cap features a first-opening indication security solution that prevents the illegal reuse of medicine containers under the guise of being unopened, original products.

In addition, Flexi-Cap has a label combined with a cap, which is similar to the cover for wine bottles, but adapted to specific requirements of the pharmaceutical industry. The result is a clear and irreversible indication that a primary container has been opened.

The film cap is positioned over the closed container, and then the label is applied without covering the peel-open tab of the opening strip.

Once the strip is opened, the bottom part of the cap, together with the label, remains attached to the container. Attempting to remove the rest of the cap destroys the label, eliminating the possibility of unnoticed illegal reuse.

Flexi-Cap enables flexible use with different container types, forms and sizes. The label construction is applied without using heat, making the solution viable for temperature-sensitive medicines.

The manufacturer’s label and brand design remain unchanged due to the combination of label and cap, while the top of the cap allows space for bar code printing or NFC chip integration for electronic tracking.

Flexi-Cap can be easily integrated into existing production processes.

Extra security features can be added such as holographs, colour-shifting inks, void effects or and LaserSecure technology.

Schreiner MediPharm US president Gene Dul said: "Flexi-Cap’s innovative security concept allows for flexible, customised implementation of a highly effective anti-counterfeiting tactic.

"It accomplishes this by yielding plainly apparent physical and visual evidence of a container’s use, ones that vastly diminish the potential for illicit market reintroduction."

More than a million needlestick injuries occur in European hospitals and private medical practices every year.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology